We used MCF7 (non-triple-negative) and MDAMB231 (triple-negative) breast cancer cell lines to perform chemotherapy resistance experiments and verify the expression of PFDN4 in MCF7 and MDAMB231 cells. This evidence concerns the gene PFDN4 and breast carcinoma.